Which of the following is seen in osteoporosis:
First, the core concept. Osteoporosis is a metabolic bone disease characterized by low bone mass and structural deterioration of bone tissue. Key terms here are bone mineral density, trabecular bone, and risk factors like age and estrogen deficiency. The main issue is reduced BMD leading to fragile bones.
Next, why the correct answer is right. BMD is measured via DEXA scans, and a T-score of β€ -2.5 defines osteoporosis. The pathophysiology involves an imbalance between bone resorption and formation, often due to increased osteoclast activity. Estrogen deficiency in postmenopausal women is a major factor because estrogen inhibits osteoclasts. So decreased BMD is a hallmark.
Now, the wrong options. If the options included things like increased bone turnover markers, that's a distractor. While turnover markers can be elevated, the diagnosis is based on BMD. Fracture risk is a consequence, not a diagnostic feature. Osteopenia is a precursor but not the same as osteoporosis.
Clinical pearl: Remember that BMD measurement is the gold standard. Also, the T-score comparison to young adults is crucial for diagnosis. High-yield fact: Osteoporosis is silent until a fracture occurs, so screening is important for at-risk groups.
Make sure the explanation is concise, fits within the character limit, and uses proper medical terms. Check for any formatting issues and ensure each section is clearly labeled. Avoid markdown except for bold labels and key terms. Keep the language clear for postgraduate students.
**Core Concept**
Osteoporosis is a metabolic bone disorder characterized by **reduced bone mineral density (BMD)** and microarchitectural disruption, leading to increased fracture risk. The primary diagnostic criterion is a **T-score β€ -2.5** on dual-energy X-ray absorptiometry (DEXA) compared to young adult reference values.
**Why the Correct Answer is Right**
**Decreased BMD** is the defining feature of osteoporosis. It results from an imbalance between bone resorption (mediated by osteoclasts) and bone formation (mediated by osteoblasts), often due to estrogen deficiency (postmenopausal), aging, or secondary causes like glucocorticoid use. Bone remodeling is disrupted, with increased osteoclast activity outpacing osteoblast function, leading to net bone loss. DEXA quantifies this loss, with lower BMD correlating directly with fracture risk.
**Why Each Wrong Option is Incorrect**
**Option A:** *Increased trabecular bone thickness* β Incorrect. Osteoporosis causes **thinning of trabeculae** and reduced cortical thickness, not increased thickness.
**Option B:** *Elevated serum calcium* β Incorrect. Osteoporosis itself does not cause hypercalcemia; secondary hyperparathyroidism (due to low calcium) may occur but is not diagnostic.
**Option D:** *Normal bone turnover markers* β Incorrect. Bone turnover markers (e.g., CTX